The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
September 19th 2024
EDG-7500 was well-tolerated in healthy patients in Phase 1 while achieving gradient relief without LVEF reductions in the Phase 2 CIRRUS-HCM trial.
September 12th 2024
September 10th 2024
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
In Hemodialysis Patients, Renin-Angiotensin System Inhibitors Reduce All-Cause Mortality Risk
November 9th 2013A recent study found that drug regimens containing renin-angiotensin system (RAS) inhibitors are associated with a lower risk of cardiovascular and all-cause deaths among patients starting hemodialysis, compared to regimens containing only beta blockers (BBs).
Preventative Measures for Upper Gastrointestinal Tract Bleeding
Primary prevention measures for upper GI bleeding should include NSAIDs, antiplatelet therapy, and anticoagulants appropriately, while secondary preventive measures should include testing and treating H. pylori and using long-term PPIs when appropriate.
New Oral Anticoagulants Carry Risks and Benefits in Venous Thromboembolism
In his "Venous Thromboembolism: New Evidence and Best Practice" presentation, Steven Deitelzweig, MD, a hospitalist at Ochsner Medical Center, reviewed new oral anticoagulants (NOACs) used to treat venous thromboembolism (VTE).
Vascular Calcification Shown on X-Ray Assesses Cardiovascular Risks in Chronic Kidney Disease
November 8th 2013A recent study presented at Kidney Week 2013 suggests that a plain X-ray is a reliable and inexpensive tool for assessing the risks of cardiovascular events and death in patients who have chronic kidney disease (CKD) and are not on dialysis.
Aggressive Cardiac Rehabilitation Improves Outcomes in Chronic Heart Failure Patients
November 1st 2013Results of a randomized controlled trial demonstrate that a long-term, supervised, moderate-intensity exercise training program for chronic heart failure patients can produce improvements in hospital readmission and survival rates.
Tocilizumab Treatment Associated with Cardiovascular Improvements in RA Patients
Though rheumatoid arthritis (RA) patients have a significantly higher risk of developing cardiovascular disease (CVD) compared to the general population, results from a pair of studies show that the biologic disease modifier Actemra (tocilizumab) may actually improve the cardiovascular (CV) profiles of RA patients.
Smoking Cessation and Off-Label Therapies May Be Most Potent Treatment for COPD Exacerbations
October 29th 2013Doctors treating patients for COPD exacerbations may have recourse to a variety of treatments, including some off-label applications of existing drugs, and smoking cessation may result in a reduction of repeat occurrences.
Less Bleeding Associated with Novel Anticoagulants, but Use Not Recommended for all Patients
October 29th 2013Presentation at CHEST 2013 reviewed key considerations surrounding the treatment of pulmonary embolism and other venous thromboembolic events with the newer class of oral anticoagulant agents.
When Prophylaxis Is Contraindicated, Inferior Vena Cava Filter Can Benefit VTE
October 22nd 2013Mechanical prophylaxis for pulmonary embolism (PE) in the form of an inferior vena cava filter (IVCF) is an option for surgical patients who can't undergo chemical venous thromboembolism (VTE) prophylaxis.
Heart Association Highlights Risks of Severe Obesity in Children
The American Heart Association (AHA) has released a scientific statement on severe obesity in children and adolescents highlighting the health risks, challenges, and limitations of treatment for this issue.